fbpx
Loading …

Categories

In Conversation

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow May 7, 2019 In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP)

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP)

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the Workshop Director for the upcoming Bio-TracⓇ Symposium, “Laser Microdissection: From

BioHealth Capital Projects

People on the Move

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer GAITHERSBURG, Md., Jan. 09, 2020 (Excerpts below were

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team GAITHERSBURG, Md., Jan. 09, 2020 (originally published on GLOBE NEWSWIRE)